Home FOR AUTHORS Neoplasma 2018 Neoplasma Vol.65, No.3, p.461-468, 2018

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.65, No.3, p.461-468, 2018

Title: Diagnosis of carcinoma of unknown primary site with the aid of simple PCR tests: a single-center experience
Author: E. SUSPITSIN, G. YANUS, E. IMYANITOV

Abstract: This study aimed to incorporate PCR testing in the determination of organ/tissue origin for cancers of unknown primary site (CUP). We developed a PCR panel consisting of 7 expression markers (CDX2, CDH17, SPB, UGRP, MAM, LPB, TG) and 2 genes frequently mutated in cancer (KRAS and BRAF). The expression assays were intentionally interpreted in a non-quantitative way, i.e. PCR tests classified tumors either as positive or negative expressors. While applying these tests to 135 cancers belonging to 8 common types of adenocarcinomas (AdCa), we observed that this panel was capable of clearly discriminating between gastrointestinal vs. female reproductive tract vs. lung vs. thyroid tumors in 112 (83%) of these cases and provided suggestive clues to correct diagnosis in 20 (15%) instances. We further assessed the performance of this panel coupled with the occasional use of 2 additional mutation tests (somatic: EGFR; germ-line: BRCA1) in the real diagnostic setting. The PCR analysis of 20 consecutive CUP with known IHC status turned out to be clinically useful in 19 (95%) cases, with 16 (80%) instances of resolving the existing controversy and 3 (15%) cases of providing valuable confirmation of suspected diagnosis. PCR testing of 20 consecutive CUP with unknown IHC status succeeded in establishing tumor organ/ tissue origin in 15 (75%) instances and provided suggestive clues to the diagnosis in 3 (15%) patients. We conclude that simple non-expensive laboratory-developed PCR assays may aid CUP diagnosis in a significant proportion of cases.

Keywords: carcinomas of unknown primary site, PCR, expression, mutation
Published online: 16-May-2018
Year: 2018, Volume: 65, Issue: 3 Page From: 461, Page To: 468
doi:10.4149/neo_2018_170423N304


download file



© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.